AI helps take next stride on proteins in medicine, Pg13

Key Highlights:

• Researchers have developed a new AI-powered tool named ContactSeek to enhance the precision of DNA base editing.
• ContactSeek utilizes the AlphaFold3 AI model to predict the likelihood of editor protein-DNA interactions.
• This method is more sensitive than existing 3D models, leading to improved versions of common gene editors like Cas9.
• The advancement aims to reduce off-target edits, which are accidental changes to unintended parts of a person's DNA during gene therapy.

Detailed Insights:

• DNA base editing is a gene therapy technique that chemically alters a single DNA base without creating a double-strand break.
• The primary challenge with current base editors is their tendency to cause unintended changes, known as off-target effects.
• ContactSeek addresses this by accurately predicting which parts of an editor protein will interact with DNA, guiding the design of more specific editors.
• AlphaFold3, developed by DeepMind, is an advanced AI system capable of predicting the 3D structures of biological molecules and their interactions.
• Improved Cas9 editors resulting from ContactSeek could significantly enhance the safety and efficacy of gene therapies for various genetic diseases.
• This development represents a significant stride in precision medicine, moving towards safer and more reliable genetic interventions.

Scientific/Technical Concepts Involved:

• DNA Base Editing: A gene-editing technique that precisely changes a single DNA base (e.g., A, T, C, G) without cutting the DNA double helix.
• AlphaFold3: An artificial intelligence model that predicts the 3D structures of proteins, DNA, RNA, and ligands, and their interactions.
• Cas9: A bacterial enzyme that acts as molecular scissors in the CRISPR-Cas9 system, used to cut DNA at specific locations for gene editing.
• Off-target edits: Unintended and potentially harmful changes made by gene-editing tools to parts of the genome other than the desired target.